The Truth About Biotech Penny Stocks
December 22nd, 2009 at 2:54 pm Posted by The Dean
Investing in biotechnology companies is particularly risky because long term gains aren’t predictable and easy to come by. But, the potential to make short term gains by investing in biotech penny stocks is common because these types of companies are typically popularized through product development, research efforts, receipt of funding and, hopefully, some type of current or future clinical trials.
Like any type of small cap stock, biotech penny stocks present the opportunity to make a log of money in the long-term with thorough research, patience and even a little bit of luck.
In the over-the-counter (OTC) markets, there must be several hundred biotech penny stocks (if not more) being watched by an even larger amount of anxious investors waiting to pounce on, or sell-out of, a position.
Biotech penny stocks can really attract investors and heavy volume because advancements in medicine, science, technology and engineering have enormous potential. Why’s that? The industries themselves have billions of dollars flowing through them every year.
The more you do your homework on biotechnology companies and their trading activity, there more you might be able to gauge how a stock can respond to business updates, press releases or even being recognized in the news or at any number of medical and pharmaceutical conferences throughout the year.
Of course, many people are looking for biotech penny stocks that have future “blue chip” potential and that’s what makes investing in biotechnology companies so popular and exciting.
By the same account, bio tech companies that are merely shells have an even shorter life span. That’s why i only jump in when they are they pumped and out of them by the next day or 2 with a small profit or in some cases a small loss!!